Romilar supply may be suspended next year.

Published: 2006-12-22 06:59:00

Updated: 2006-12-22 06:59:00

Bayer Healthcare announced on Dec. 20 that Romilar (dextromethorphan) tablet, an anti-cough medicine, manufactured by Roche Korea but supplied by Bayer in Korea had faced to stop supplying it in Korea due to the withdrawal of Roche Korea plant next year.

Considering its inventory kept remnant ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK